Suehiro A, Oura Y, Ueda M, Kakishita E
Second Department of Internal Medicine, Hyogo College of Medicine, Japan.
Res Commun Chem Pathol Pharmacol. 1994 Feb;83(2):157-63.
To examine whether the dosage of a platelet-suppressive agent at which an antithrombotic effect is adequate and bleeding tendency is not increased can be found, the antithrombotic effects, antiplatelet effects and bleeding times of ticlopidine and aspirin were investigated in the rat experimental thrombus formation model. Thrombus formation was determined by measuring the change in wet weight of a silk thread placed in a carotid arteriovenous shunt. Ticlopidine inhibited thrombus formation and platelet aggregation at rather low doses (50-100 mg/kg) without prolonging bleeding time. However, aspirin did not inhibit thrombus formation at even the highest examined dose (200 mg/kg), while bleeding time was prolonged at even the lowest dose (50 mg/kg). These results suggest that a dosage of antithrombotic agent that does not increase bleeding tendency can be easily established using ticlopidine, although it is relatively difficult using aspirin.
为了研究是否能够找到一种血小板抑制药物的剂量,使其抗血栓作用充分且不增加出血倾向,我们在大鼠实验性血栓形成模型中研究了噻氯匹定和阿司匹林的抗血栓作用、抗血小板作用及出血时间。通过测量置于颈动脉动静脉分流处丝线湿重的变化来确定血栓形成情况。噻氯匹定在相当低的剂量(50 - 100 mg/kg)时就能抑制血栓形成和血小板聚集,且不延长出血时间。然而,即使在最高检测剂量(200 mg/kg)下,阿司匹林也不能抑制血栓形成,而即使在最低剂量(50 mg/kg)时出血时间就会延长。这些结果表明,使用噻氯匹定能够轻松确定一种不增加出血倾向的抗血栓药物剂量,而使用阿司匹林则相对困难。